Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prolactinomas”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Post-approval studies (Phase 4)Looking for participantsNCT07045935
What this trial is testing

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

Who this might be right for
Prolactinoma
University Hospital, Basel, Switzerland 60
Not applicableUnknownNCT03717454
What this trial is testing

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Who this might be right for
Prolactinoma
Zhebao Wu 50
Testing effectiveness (Phase 2)Looking for participantsNCT06295952
What this trial is testing

Pasireotide in People With Prolactinoma

Who this might be right for
Prolactin-Producing Pituitary Tumor
Memorial Sloan Kettering Cancer Center 10
Not applicableUnknownNCT02854228
What this trial is testing

PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon

Who this might be right for
Pituitary Tumor
Hospices Civils de Lyon 1,300
Not applicableUnknownNCT03457389
What this trial is testing

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Who this might be right for
Pituitary AdenomaProlactinomaPituitary Tumor+1 more
Seoul National University Hospital 68
Not applicableUnknownNCT01143584
What this trial is testing

Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.

Who this might be right for
Macroprolactinoma
Post Graduate Institute of Medical Education and Research, Chandigarh 20
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Not applicableUnknownNCT01775332
What this trial is testing

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools

Who this might be right for
Pituitary NeoplasmsProlactinomaACTH-Secreting Pituitary Adenoma+2 more
Unity Health Toronto 60
Testing effectiveness (Phase 2)Study completedNCT03038308
What this trial is testing

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Who this might be right for
HyperprolactinemiaProlactinoma
Columbia University 16
Not applicableStudy completedNCT00481299
What this trial is testing

Insulin Resistance in Women With Prolactinoma

Who this might be right for
ProlactinomaInsulin ResistanceHyperlipidemia
Universidade Federal do Rio de Janeiro 2,004
Testing effectiveness (Phase 2)Study completedNCT00939523
What this trial is testing

Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy

Who this might be right for
Pituitary AdenomasProlactinomas
Cedars-Sinai Medical Center 9
Large-scale testing (Phase 3)Study completedNCT01620138
What this trial is testing

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Who this might be right for
Non-functioning Pituitary AdenomasProlactinomas
Universidade Federal do Rio de Janeiro 21
Testing effectiveness (Phase 2)WithdrawnNCT00601289
What this trial is testing

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT01504399
What this trial is testing

Rhinological Outcomes in Endonasal Pituitary Surgery

Who this might be right for
Pituitary NeoplasmPituitary AdenomaProlactinoma+2 more
St. Joseph's Hospital and Medical Center, Phoenix 235
Post-approval studies (Phase 4)Looking for participantsNCT04107480
What this trial is testing

PRolaCT - Three Prolactinoma RCTs

Who this might be right for
ProlactinomaProlactin-Producing Pituitary Tumor
Leiden University Medical Center 880
Not applicableLooking for participantsNCT00001595
What this trial is testing

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Who this might be right for
PanhypopituitarismGigantism/AcromegalyProlactinoma+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,000
Early research (Phase 1)UnknownNCT01344291
What this trial is testing

Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients

Who this might be right for
Hyperprolactinoma
Mashhad University of Medical Sciences 30
Not applicableUnknownNCT03400865
What this trial is testing

Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas

Who this might be right for
Resistance, DiseaseProlactinoma
Zhebao Wu 30
Not applicableActive Not RecruitingNCT06936813
What this trial is testing

The PROMISE Survey

Who this might be right for
ProlactinomaPituitary Tumor
University Hospital, Basel, Switzerland 530
Not applicableNot Yet RecruitingNCT06556186
What this trial is testing

Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma

Who this might be right for
Pituitary Tumor
Second Affiliated Hospital, School of Medicine, Zhejiang University 600
Load More Results